The treatment group will receive SurgX™ Antimicrobial Wound Gel™ applied over incision after closure and then re-applied at first dressing change on day of discharge in addition to standard of care.

The control group will receive standard of care.

In addition to standard of care, at time of surgery, SurgX applied on the incision after closure and then re-applied at the time of first bandage change on day of discharge.

Presence/absence of a surgical site complication. Surgical site complications to be defined as meeting at least one of the below criteria:

1. Bacterial or fungal infection as confirmed by PCR swabs
2. Hypertrophic scar formation as diagnosed by in-person assessment via the study investigator
3. Superficial granuloma formation as diagnosed by in-person assessment via study investigator
4. Wound dehiscence as diagnosed by in-person assessment via study investigator
5. Presence of discharge as diagnosed by in-person assessment via study investigator
6. Presence of wound redness as diagnosed by in-person assessment via study investigator
7. Presence of stitch abscess as diagnosed by in-person assessment via study investigator
8. Superficial surgical site infection as diagnosed by in-person assessment via study investigator in accordance with the NHSN SSI Checklist

Third party assessment of wound images taken with Tissue Analytics via blinded assessor to corroborate the investigator's assessment using the below criteria:

1. Hypertrophic scar formation
2. Superficial granulation
3. Wound dehiscence
4. Discharge
5. Wound redness
6. Stitch abscess